Assess whether the carve-out is operable on day one (4b0892)
August 31, 2026
SITUATION In a health-system acquiring a specialty practice, customer concentration and termination-for-convenience clauses is the evidence after IT diligence showing two ERPs and no chart of accounts map. Buy-side QoE lead has to pick Proceed or Reprice for this M&A Due Diligence Legal, IP, and Regulatory close using customer concentration and termination-for-convenience clauses.
DECISION Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using customer concentration and termination-for-convenience clauses after IT diligence showing two ERPs and no chart of accounts map.
HYPOTHESES TO TEST 1. Authorize Proceed now; customer concentration and termination-for-convenience clauses already has the discriminator after IT diligence showing two ERPs and no chart of accounts map. 2. Keep Reprice in force until customer concentration and termination-for-convenience clauses is completed after IT diligence showing two ERPs and no chart of accounts map for buy-side QoE lead. 3. Treat customer concentration and termination-for-convenience clauses as Walk because both readings appear after IT diligence showing two ERPs and no chart of accounts map. 4. Refuse a M&A Due Diligence close: buy-side QoE lead does not have the decision the carve-out is operable turns on in customer concentration and termination-for-convenience clauses.
ANALYSIS REQUIRED 1. Tie quality-of-earnings, working-capital, and contingent items in customer concentration and termination-for-convenience clauses to the carve-out is operable. 2. Name the document buy-side QoE lead still needs before signing. 3. Test whether IT diligence showing two ERPs and no chart of accounts map is a diligence gap, a price chip, or a walk-away. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read customer concentration and termination-for-convenience clauses against IT diligence showing two ERPs and no chart of accounts map and write the one fact that would move the carve-out is operable for buy-side QoE lead.
RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (customer concentration and termination-for-convenience clauses after IT diligence showing two ERPs and no chart of accounts map). Lead with the M&A Due Diligence option customer concentration and termination-for-convenience clauses can support after IT diligence showing two ERPs and no chart of accounts map, then the two facts that force it, then the Monday action for buy-side QoE lead in a health-system acquiring a specialty practice.
COMMAND RETURNS - Bottom-line M&A Due Diligence option on the carve-out is operable, then the evidence in customer concentration and termination-for-convenience clauses, then the action for buy-side QoE lead - Hypothesis scorecard against customer concentration and termination-for-convenience clauses: supported / rejected / untestable - Legal, IP, and Regulatory finding in customer concentration and termination-for-convenience clauses that a second reviewer can re-perform - Missing page in customer concentration and termination-for-convenience clauses after IT diligence showing two ERPs and no chart of accounts map, if any
Explore more
More M&A Due Diligence prompts
- Assess whether the carve-out is operable on day one (4d8da7)
- Assess whether environmental liability is capped or open-ended (0be910)
- Assess whether the carve-out is operable on day one (e45576)
- Assess whether management can run this without the founder (f4c830)
- Assess whether to re-trade, restructure, or drop (60a1c4)
Explore related decision areas
- Assess whether CAT pricing is defensible given SOV quality (62bb1b)Insurance Underwriting
- Assess whether CMMC gaps are bid-killers or post-award plans (a9efc6)Government RFP
- Assess whether a control deficiency is significant or material (d7c542)Forensic Accounting
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

